L G And Doctor Associates Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 31-10-2024
- Paid Up Capital ₹ 0.50 M
as on 31-10-2024
- Company Age 42 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -38.54%
(FY 2023)
- Profit -209.64%
(FY 2023)
- Ebitda -154.57%
(FY 2023)
- Net Worth -23.78%
(FY 2023)
- Total Assets -20.54%
(FY 2023)
About L G And Doctor Associates
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vinod Soni, Kiran Jhaveri, and Manan Shah serve as directors at the Company.
- CIN/LLPIN
U15319GJ1982PTC005437
- Company No.
005437
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does L G And Doctor Associates Private Limited offer?
L G And Doctor Associates Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed, Food Grains, Maize Bran, Oil Cake, Flavours & Aromatics, Starch Powder, Natural Sweetener, Cooking Oil, Corn Oil.
Who are the key members and board of directors at L G And Doctor Associates?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Soni  | Whole-Time Director | 06-Jan-2014 | Current |
| Kiran Jhaveri | Director | 20-Aug-2022 | Current |
| Manan Shah | Director | 06-Oct-2022 | Current |
Financial Performance of L G And Doctor Associates.
L G And Doctor Associates Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 38.54% decrease. The company also saw a substantial fall in profitability, with a 209.64% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of L G And Doctor Associates?
In 2023, L G And Doctor Associates had a public holding of 11.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at L G And Doctor Associates?
Unlock and access historical data on people associated with L G And Doctor Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L G And Doctor Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L G And Doctor Associates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
